- Home
- CLH vs EXAS Comparison
CLH vs EXAS Comparison
Compare CLH & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLH
- EXAS
- Stock Information
- Founded
- CLH 1980
- EXAS 1995
- Country
- CLH United States
- EXAS United States
- Employees
- CLH N/A
- EXAS N/A
- Industry
- CLH Environmental Services
- EXAS Medical Specialities
- Sector
- CLH Industrials
- EXAS Health Care
- Exchange
- CLH Nasdaq
- EXAS Nasdaq
- Market Cap
- CLH 13.9B
- EXAS 12.3B
- IPO Year
- CLH 1987
- EXAS N/A
- Fundamental
- Price
- CLH $250.02
- EXAS $53.07
- Analyst Decision
- CLH Strong Buy
- EXAS Strong Buy
- Analyst Count
- CLH 9
- EXAS 17
- Target Price
- CLH $258.11
- EXAS $73.07
- AVG Volume (30 Days)
- CLH 399.4K
- EXAS 3.5M
- Earning Date
- CLH 10-30-2024
- EXAS 11-05-2024
- Dividend Yield
- CLH N/A
- EXAS N/A
- EPS Growth
- CLH 15.34
- EXAS N/A
- EPS
- CLH 7.68
- EXAS N/A
- Revenue
- CLH $5,797,005,000.00
- EXAS $2,692,328,000.00
- Revenue This Year
- CLH $10.09
- EXAS $12.41
- Revenue Next Year
- CLH $6.01
- EXAS $11.64
- P/E Ratio
- CLH $32.59
- EXAS N/A
- Revenue Growth
- CLH 8.37
- EXAS 11.91
- 52 Week Low
- CLH $158.42
- EXAS $40.62
- 52 Week High
- CLH $267.11
- EXAS $79.62
- Technical
- Relative Strength Index (RSI)
- CLH 49.55
- EXAS 36.19
- Support Level
- CLH $240.00
- EXAS $48.72
- Resistance Level
- CLH $265.72
- EXAS $54.55
- Average True Range (ATR)
- CLH 6.02
- EXAS 3.03
- MACD
- CLH -0.78
- EXAS -0.39
- Stochastic Oscillator
- CLH 50.60
- EXAS 20.35
About CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About EXAS Exact Sciences Corporation
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.